Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Trifluoromethyl Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ru-catalyzed synthesis of trifluoromethyl quinazolinones. High yield, green solvent, excellent antibacterial activity for agrochemical manufacturing.
Patent CN119490461A reveals metal-free synthesis for high-purity quinazolinone derivatives offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN118515620A details a heterogeneous Pd/ACFs catalytic method for high-purity quinazolinone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101351459A reveals a novel acetic acid-catalyzed route for 4(3H)-quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates like Rutaecarpine.
Patent CN113045503A reveals a robust palladium-catalyzed route for 2-trifluoromethyl quinazolinones, offering superior yields and scalability for API manufacturing.
Patent CN112480015B reveals a mild one-pot synthesis for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed carbonylation method for quinazolinones. High yield, scalable route for drug molecules like Rutaecarpine.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel FeCl3-catalyzed route offers high yield and scalability for drug intermediates, reducing costs in API manufacturing.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112480015B reveals a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and high purity.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope for efficient drug molecule synthesis.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and scalability for API manufacturing.
Novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN112480015B details a one-pot method for quinazolinones, offering cost-effective routes for pharmaceutical intermediates and improved supply chain reliability.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production.